Fuqiang Wen Selected Research

Fuqiang Wen Research Topics

Disease

40	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 02/2012
31	Inflammation (Inflammations) 07/2022 - 01/2008
8	Neoplasms (Cancer) 10/2021 - 01/2014
6	Acute Lung Injury 07/2022 - 12/2012
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2022 - 10/2018
5	Malignant Pleural Effusion 08/2017 - 01/2014
4	Sepsis (Septicemia) 07/2022 - 11/2017
4	Asthma (Bronchial Asthma) 01/2022 - 10/2013
4	Pneumonia (Pneumonitis) 11/2020 - 12/2012
4	Pleural Effusion (Pleural Effusions) 12/2017 - 01/2015
3	Lung Injury 07/2022 - 01/2018
3	Disease Progression 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 06/2021 - 11/2014
3	Hyperplasia 01/2021 - 05/2012
3	Lung Neoplasms (Lung Cancer) 01/2019 - 05/2013
3	Pulmonary Tuberculosis 03/2016 - 01/2010
2	Pulmonary Edema 07/2022 - 10/2018
2	Lung Diseases (Lung Disease) 12/2021 - 11/2016
2	Infections 12/2021 - 10/2018
2	Adenocarcinoma of Lung 10/2021 - 04/2017
2	Emphysema 01/2021 - 10/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2020 - 01/2018
2	Chronic Cough 11/2020 - 01/2018
2	Airway Remodeling 04/2020 - 10/2013
2	Edema (Dropsy) 01/2018 - 01/2008
2	Tuberculosis (Tuberculoses) 01/2017 - 01/2010
2	Necrosis 01/2016 - 08/2005
2	Carcinoma (Carcinomatosis) 03/2015 - 07/2007
1	Dyspnea (Shortness of Breath) 01/2022
1	Hyperoxia 12/2021
1	Human Influenza (Influenza) 12/2021
1	Chronic Bronchitis 07/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Mycoplasma Pneumonia 01/2021
1	Bronchitis 11/2020
1	Bronchiolitis 10/2019

Drug/Important Bio-Agent (IBA)

21	SmokeIBA 12/2021 - 08/2005
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
10	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2010
5	GoldIBA 04/2022 - 01/2018
4	CytokinesIBA 07/2022 - 01/2013
4	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 10/2017
4	LipopolysaccharidesIBA 12/2021 - 12/2012
4	Messenger RNA (mRNA)IBA 01/2021 - 12/2012
4	C-Reactive ProteinIBA 01/2019 - 07/2013
4	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2012
4	Receptor for Advanced Glycation End ProductsIBA 10/2018 - 04/2014
3	AntioxidantsIBA 07/2022 - 05/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 02/2015
3	AntigensIBA 01/2021 - 06/2015
3	Interleukin-8 (Interleukin 8)IBA 10/2018 - 12/2012
3	InterleukinsIBA 10/2018 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 01/2015
3	LigandsIBA 08/2015 - 01/2012
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022 - 01/2015
2	Peptides (Polypeptides)IBA 01/2021 - 01/2010
2	Nucleic AcidsIBA 01/2021 - 05/2015
2	Particulate MatterIBA 11/2020 - 01/2018
2	EndostatinsIBA 01/2020 - 06/2015
2	Circular RNAIBA 10/2019 - 01/2019
2	MucinsIBA 02/2018 - 05/2012
2	FlavonoidsIBA 02/2018 - 04/2015
2	SurvivinIBA 01/2018 - 01/2014
2	Tumor Biomarkers (Tumor Markers)IBA 08/2017 - 04/2017
2	Carcinoembryonic AntigenIBA 08/2017 - 04/2017
2	antigen CYFRA21.1IBA 08/2017 - 04/2017
2	p38 Mitogen-Activated Protein KinasesIBA 01/2017 - 11/2016
2	SilymarinIBA 11/2016 - 04/2015
2	AdiponectinIBA 01/2016 - 09/2015
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014 - 09/2009
1	Serum AlbuminIBA 07/2022
1	Cysteine (L-Cysteine)FDA Link 07/2022
1	Leucine (L-Leucine)FDA Link 07/2022
1	ThioredoxinsIBA 07/2022
1	fudosteineIBA 07/2022
1	NucleotidesIBA 07/2022
1	PyrinIBA 07/2022
1	CateninsIBA 01/2022
1	prednylidene (Pred)IBA 01/2022
1	GasesIBA 01/2022
1	andrographolideIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 11/2021
1	Biological ProductsIBA 07/2021
1	Biological FactorsIBA 07/2021
1	mitoquinoneIBA 01/2021
1	AngiopoietinsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2020
1	CollagenIBA 04/2020
1	Serotonin ReceptorsIBA 04/2020
1	Serotonin (5 Hydroxytryptamine)IBA 04/2020
1	Alcian BlueIBA 04/2020
1	Periodic AcidIBA 04/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020

Therapy/Procedure

3	Therapeutics 12/2021 - 03/2010
1	Drug Therapy (Chemotherapy) 07/2022
1	Punctures 07/2022
1	Ligation 07/2022
1	Activities of Daily Living (ADL) 01/2022
1	Immunotherapy 10/2021